These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 12495637

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chemokines and angiogenesis.
    Szekanecz Z, Koch AE.
    Curr Opin Rheumatol; 2001 May; 13(3):202-8. PubMed ID: 11333349
    [Abstract] [Full Text] [Related]

  • 3. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X, Oppenheim JJ, Howard OM.
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [Abstract] [Full Text] [Related]

  • 4. Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases.
    Bodolay E, Koch AE, Kim J, Szegedi G, Szekanecz Z.
    J Cell Mol Med; 2002 Oct; 6(3):357-76. PubMed ID: 12417052
    [Abstract] [Full Text] [Related]

  • 5. Chemokines and chemokine receptors in arthritis.
    Szekanecz Z, Vegvari A, Szabo Z, Koch AE.
    Front Biosci (Schol Ed); 2010 Jan 01; 2(1):153-67. PubMed ID: 20036936
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemokine inhibition in inflammatory arthritis.
    Tak PP.
    Best Pract Res Clin Rheumatol; 2006 Oct 01; 20(5):929-39. PubMed ID: 16980215
    [Abstract] [Full Text] [Related]

  • 10. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression.
    Aerts NE, De Knop KJ, Leysen J, Ebo DG, Bridts CH, Weyler JJ, Stevens WJ, De Clerck LS.
    Rheumatology (Oxford); 2010 Dec 01; 49(12):2264-72. PubMed ID: 20724433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemokines in rheumatic diseases.
    Szekanecz Z, Szücs G, Szántó S, Koch AE.
    Curr Drug Targets; 2006 Jan 01; 7(1):91-102. PubMed ID: 16454702
    [Abstract] [Full Text] [Related]

  • 13. Fractalkine in rheumatoid arthritis and allied conditions.
    Umehara H, Tanaka M, Sawaki T, Jin ZX, Huang CR, Dong L, Kawanami T, Karasawa H, Masaki Y, Fukushima T, Hirose Y, Okazaki T.
    Mod Rheumatol; 2006 Jan 01; 16(3):124-30. PubMed ID: 16767549
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis.
    Murayama MA, Shimizu J, Miyabe C, Yudo K, Miyabe Y.
    Front Immunol; 2023 Jan 01; 14():1100869. PubMed ID: 36860872
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression.
    Page G, Miossec P.
    J Pathol; 2004 Sep 01; 204(1):28-38. PubMed ID: 15307135
    [Abstract] [Full Text] [Related]

  • 18. Dynamic interactions between T cells and dendritic cells and their derived cytokines/chemokines in the rheumatoid synovium.
    Miossec P.
    Arthritis Res Ther; 2008 Sep 01; 10 Suppl 1(Suppl 1):S2. PubMed ID: 19007422
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.